Skip to content
Medical Health Aged Care

King Faisal Specialist Hospital & Research Centre Ranks 15th Globally

King Faisal Specialist Hospital & Research Centre 3 mins read

Maintaining its Leadership in the Middle East and North Africa

KFSHRC_2
Logo- kfshrc (002)

RIYADH, Saudi Arabia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- In an unprecedented achievement reflecting its excellence in specialized healthcare and medical research, King Faisal Specialist Hospital & Research Centre (KFSHRC) has been ranked 15th globally among the world’s top 250 academic medical centres (AMCs) for 2025, cementing its position as the leading hospital in the Middle East and North Africa according to the Brand Finance ranking, while advancing five spots from last year. This recognition reflects KFSHRC’s series of ground-breaking achievements on a global scale. It became the first hospital worldwide to successfully perform a fully robotic liver transplant, a fully robotic heart transplant, and a robotic implantation of an artificial heart pump. Additionally, its leadership in precision medicine and minimally invasive surgeries has reinforced its reputation as a global reference centre for complex medical specialties.

The new ranking also highlights KFSHRC’s ability to surpass conventional benchmarks of competition, positioning itself as a global hub for research and development in biomedical sciences, genomics, and organ transplantation. Furthermore, the hospital is actively shaping the future of healthcare by leveraging artificial intelligence and the latest technological innovations in diagnostics and treatment.

Saudi hospitals have achieved remarkable global recognition in the latest rankings, reflecting the Kingdom’s continuous advancements in healthcare. King Faisal Specialist Hospital & Research Centre secured the 15th position worldwide, followed by King Fahd Medical City at 60th, King Khalid University Hospital at 106th, King Saud Medical City at 113th, King Abdullah Medical City at 130th, and the National Guard Health Affairs at 143rd, while King Fahad University Hospital ranked 187th, reflecting the continuous advancement of Saudi Arabia’s healthcare sector on the global stage.

Brand Finance, founded in 1996, annually evaluates over 500 institutions across various sectors worldwide, providing strategic insights to support data-driven decision-making.

KFSHRC is among the world’s leading institutions in specialized healthcare, a pioneer in medical innovation, and an advanced centre for research and education. Committed to advancing medical technologies and elevating healthcare standards worldwide, it collaborates with prominent local, regional, and international institutions to deliver world-class clinical, research, and educational excellence.

For more information, please visit www.kfshrc.edu.sa or contact our media team at [email protected]

Photos accompanying this announcement are available at
https://www.globenewswire.com/NewsRoom/AttachmentNg/cdee52db-d7a2-4826-8f8e-2c25d1f06cee
https://www.globenewswire.com/NewsRoom/AttachmentNg/a95f4789-fa7f-4309-a10a-5adcdd9adf18


Primary Logo

More from this category

  • Medical Health Aged Care
  • 17/12/2025
  • 13:11
GE HealthCare

GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

300+ advanced CT scanners to be installed in public hospitals across 38 provinces by 2028, to support early diagnosis and treatment of non-communicable diseases.…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 17/12/2025
  • 12:03
Jane Morgan Management

LTR Pharma surpasses 1,000 SPONTAN® prescriptions under TGA Special Access Scheme

Highlights More than 1,000 SPONTAN® prescriptions issued under the TGA Special Access Scheme Growing prescriber network with continued uptake in complex ED cases, including post-prostate cancer patients Real-world insights informing US commercial strategy ahead of ROXUS® launch in H1 CY2026 LTR Pharma Limited (ASX:LTP) (“LTR Pharma” or “the Company”) is pleased to announce that more than 1,000 SPONTAN® prescriptions have now been issued in Australia under the Therapeutic Goods Administration (TGA) Special Access Scheme (SAS Category B). SPONTAN is being prescribed for patients with unmet clinical needs, including men who have not achieved adequate benefit from traditional oral PDE5 inhibitor…

  • Contains:
  • Engineering, Medical Health Aged Care
  • 17/12/2025
  • 09:02
UNSW Sydney

UNSW students claim victory in international artificial heart competition

A team of undergraduate engineering students from UNSW Sydney has claimed first place at a prestigious international artificial heart design competition in Vienna. The…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.